GlassScriptPhysician profile
Isaac I Matta
NPI 1730157686
$732.48
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $61.93 · 2022: $122 · 2023: $33.32 · 2024: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $122.40 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $112.69 | 2019 | |
| Acclarent, INC | $106.91 | 2019-2020 | |
| Integra Lifesciences Corporation | $96.77 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Olympus America INC. | $75.24 | 2019 | |
| Intersect Ent, INC. | $54.88 | 2019 | |
| Inspire Medical Systems, INC. | $42.64 | 2024 | Inspire |
| Aerin Medical INC. | $33.32 | 2023 | |
| Cochlear Americas | $32.44 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Allergan, INC. | $22.89 | 2019 | |
| Astellas Pharma US INC | $20.25 | 2019 | |
| Optinose US, INC. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Matta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.